Written Question · S1W-33207 · Session 1
What plans it has to withdraw infant vaccines that contain mercury in the light of the recent report by the UK medicines information servic…
The question
To ask the Scottish Executive what plans it has to withdraw infant vaccines that contain mercury in the light of the recent report by the UK medicines information service and what the reasons are for its position on this matter.
The answer
The Committee on Safety of Medicines has advised that, with the exception of hypersensitivity reactions that typically include skin rashes or local swelling at the site of injection, there is no evidence of harm from the levels of thiomersal (which contains ethylmercury) contained in vaccines. Further studies, and the advice of the World Health Organisation, are consistent with this finding. The benefits of immunisation outweigh any potential risks of vaccination due to sensitivity from thiomersal. However, to reduce avoidable exposure to mercury in general, it has been agreed, on a European-wide basis, that even though there is no evidence of toxicity, as a purely precautionary measure, thiomersal should be phased out over time. The Executive, the Joint Committee on Vaccination and Immunisation (JCVI) endorse this decision. Manufacturers are being encouraged to phase out the use of thiomersal in vaccines as a purely precautionary measure. It is anticipated that thiomersal-free vaccines will be considered for provision in the routine childhood immunisation programme after they have been licensed for use in the UK and have demonstrated that they are as effective in protecting children against the real risk presented by vaccine-preventable diseases as the vaccines that are currently used.The only vaccines, used routinely in the childhood immunisation programme, that contain thiomersal in the final products, are the diphtheria, tetanus and wholecell pertussis (DTwP) vaccine and the combined diphtheria and tetanus vaccine (Td). The current expert advice is that DTwP is the most effective of DTP vaccines currently available in the UK.
In the Official Report
No contribution in the Official Report cites S1W-33207 by reference.